Spatial Genomics
Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.
Founded
2016Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.
Spatial Genomics, founded with a mission to revolutionize biological research, focuses on pioneering spatial analysis and comprehensive single-cell assays within intact cells and tissues. Their core vision is to advance fundamental biology, precision medicine, drug development, and diagnostics through highly multiplexed spatial analysis. The company offers the GenePS device, a sensitive confocal imager combined with advanced fluidics, designed to empower spatial research and deliver exceptional results.
Notable figures in the company include leading experts in genomics and biotechnology. Spatial Genomics has attracted significant investment from prominent venture capital firms specializing in life sciences. Key achievements include the successful deployment of their GenePS device in various research institutions, contributing to groundbreaking discoveries in gene expression and protein analysis. The company's impact is evident in its role in advancing precision medicine and enhancing the understanding of complex biological systems.
Companies similar to Spatial Genomics include Rebus Biosystems, Singular Genomics, 10x Genomics and AtlasXomics.
Spatial Genomics was founded in 2016.
Spatial Genomics' headquarters is located in Pasadena, CA, US.
Spatial Genomics' most recent funding round was for $56M (USD) in February 2022.
As of Feb 23, 2022, Spatial Genomics has disclosed funding of $56M (USD). Undisclosed round amounts are excluded.
Spatial Genomics has 24 employees as of Feb 4, 2024.
AtlasXomics
atlasxomics.com
